Clinical Trial Update: Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas [Phase 2]

View source ↗

Summary

Phase II trial of perifosine for recurrent/progressive malignant gliomas completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Central Nervous System Cancer
• Malignant Glioma

Drugs mentioned

• Perifosine (perifosine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Malignant Gliomas, CNS | Phase 2 | Status: COMPLETED | Results posted: 2020-10-19